Oramed Pharmaceuticals Inc.
ORMP | TA
Overview
Corporate Details
- ISIN(s):
- US68403P2039
- LEI:
- Country:
- Israel
- Address:
- 20 Mamilla Avenue, 9414904 Jerusalem
- Website:
- https://www.oramed.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Oramed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company specializing in the development of oral drug delivery systems. The company's proprietary Protein Oral Delivery (POD™) technology is designed to enable the oral administration of drugs, such as proteins, that are currently administered only by injection. Its flagship product candidate is an oral insulin capsule intended for the treatment of type 2 diabetes. Oramed's mission is to transform the treatment of diseases by providing more convenient, safer, and effective oral alternatives to injectable medications, thereby improving patient compliance and comfort.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Oramed Pharmaceuticals Inc..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-22 09:42 |
Post-Annual General Meeting Information
Other Report or Announcement
|
English | 118.7 KB | |
| 2025-08-22 09:42 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB | |
| 2025-08-22 09:41 |
Registration Form
Other Report or Announcement
|
English | 181.3 KB | |
| 2025-08-22 09:41 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB | |
| 2025-08-17 15:18 |
Foreign Filer Report
FORM 10-Q- FINANCIAL STATEMENTS AS OF JUNE 30, 2025
|
English | 36.4 KB | |
| 2025-08-17 15:16 |
Major Shareholding Notification
Form 13G
|
English | 93.7 KB | |
| 2025-08-17 15:16 |
Foreign Filer Report
Form 13G
|
English | 36.4 KB | |
| 2025-07-23 17:53 |
Delisting Announcement
Option Agreement for the Repurchase of Warrants
|
English | 316.7 KB | |
| 2025-07-23 17:53 |
Foreign Filer Report
Option Agreement for the Repurchase of Warrants
|
English | 36.4 KB | |
| 2025-07-18 14:52 |
Proxy Solicitation & Information Statement
Other Report or Announcement
|
English | 1.4 MB | |
| 2025-07-18 14:52 |
Proxy Solicitation & Information Statement
Other Report or Announcement
|
English | 36.4 KB | |
| 2025-07-18 14:51 |
Registration Form
Other Report or Announcement
|
English | 448.1 KB | |
| 2025-07-18 14:51 |
Registration Form
Other Report or Announcement
|
English | 36.4 KB | |
| 2025-07-18 14:50 |
Annual / Quarterly Financial Statement
Other Report or Announcement
|
English | 359.9 KB | |
| 2025-07-18 14:50 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB |
Automate Your Workflow. Get a real-time feed of all Oramed Pharmaceuticals Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oramed Pharmaceuticals Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
